Aperiomics

Based in Sterling, Virginia, Aperiomics is a biotechnology company that provides advanced infectious disease diagnostics using deep shotgun metagenomic sequencing and proprietary bioinformatics. The organization utilizes machine learning to analyze patient samples and detect up to 40,000 microorganisms, including over 12,000 clinically relevant pathogens such as bacteria, viruses, fungi, and parasites. Operating with a team of under 50 employees, the diagnostic testing provider secured approximately $1.8 million in Series A funding to expand its clinical, research, and public health applications. The enterprise received financial backing from venture investors including Pipeline Angels to scale its testing capabilities before ultimately being acquired and integrated by global life sciences corporation Labcorp in August 2021. Aperiomics was founded in 2013 as a spin-out from George Washington University by Crystal Icenhour, Keith Crandall, Eduardo Castro-Nallar, and Paul Roepe.